
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    Here's a detailed analysis to identify the cell type based on the provided marker list:<br><br>**Analysis of Single-Cell Cluster Markers**<br><br>**1. List the Key Functional Markers:**<br><br>*   **NKG7 (Natural Killer Cell Granule Protein 7):** A transmembrane protein found in the granules of natural killer (NK) cells and cytotoxic T lymphocytes (CTLs). It is involved in granule exocytosis and cytotoxicity. Its presence strongly suggests a cytotoxic immune cell lineage.<br>*   **CCL5 (Chemokine (C-C motif) Ligand 5, also known as RANTES):** A chemokine that recruits various immune cells, including T cells, eosinophils, and basophils, to sites of inflammation. While not exclusive to one cell type, its high expression in conjunction with cytotoxic markers points towards activated immune cells.<br>*   **KLRD1 (Killer Cell Lectin Like Receptor D1, also known as CD94):** A C-type lectin receptor expressed on the surface of NK cells and a subset of T cells (NKT cells and some CD8+ T cells). It forms a heterodimer with NKG2A, recognizing HLA-E and inhibiting NK cell cytotoxicity. Its presence is a strong indicator of NK cells or NKT cells.<br>*   **GZMM (Granzyme M):** A serine protease found in the granules of cytotoxic lymphocytes (NK cells and CTLs). Granzymes are crucial for inducing target cell apoptosis. Its presence is a definitive marker of cytotoxic activity.<br>*   **GZMA (Granzyme A):** Another serine protease found in cytotoxic granules, similar to GZMM, also involved in inducing target cell death. Its co-expression with GZMM further reinforces the cytotoxic immune cell identity.<br>*   **TRGC2 (T Cell Receptor Gamma Constant 2):** A component of the gamma-delta T cell receptor. The presence of TCR gamma chain suggests a T cell lineage, specifically gamma-delta T cells if paired with a delta chain.<br>*   **WIPF1 (WAS/WASL Interacting Protein Family Member 1):** Involved in actin polymerization and cell motility, particularly important in immune cell function, including cytotoxic granule formation and movement.<br>*   **PTGER4 (Prostaglandin E Receptor 4, also known as EP4):** A receptor for prostaglandin E2, involved in various immune responses, including T cell activation and differentiation. Its presence suggests immune cell activity and responsiveness to inflammatory signals.<br>*   **B2M (Beta-2 Microglobulin):** A component of MHC class I molecules. Highly expressed in most nucleated cells, but its high expression in immune cells, particularly those involved in antigen presentation or recognition (like T cells and NK cells), is expected.<br>*   **HLA-A (Major Histocompatibility Complex, Class I, A):** A classical MHC class I molecule. Similar to B2M, its expression is widespread but crucial for T cell recognition of infected or cancerous cells.<br>*   **CD52:** A glycosylphosphatidylinositol (GPI)-anchored glycoprotein expressed on the surface of lymphocytes, monocytes, and macrophages. While not specific to cytotoxic cells, its presence is consistent with a leukocyte population.<br><br>**2. List the Key Cell Type Markers:**<br><br>*   **NKG7, KLRD1, GZMM, GZMA:** These are the most definitive markers for **Natural Killer (NK) cells** and **cytotoxic T lymphocytes (CTLs)**. The co-expression of multiple granzymes (GZMA, GZMM) and NK-specific receptors (NKG7, KLRD1) is highly characteristic of these cytotoxic lineages.<br>*   **TRGC2:** This marker specifically points towards **gamma-delta T cells**.<br>*   **CCL5:** While functional, its high expression is often seen in activated NK cells and T cells.<br>*   **RPS/RPL genes (e.g., RPL36AL, RPS15A, RPS27A, RPS16, RPS3, RPS29, RPS19, RPLP2, RPS27, RPL28):** These are ribosomal protein genes. High expression of ribosomal proteins often indicates high metabolic activity and protein synthesis, which is characteristic of highly active and proliferating immune cells.<br>*   **TMSB4X (Thymosin Beta 4, X-linked):** An actin-sequestering protein involved in cell motility and organization of the cytoskeleton. Highly expressed in many cell types, but its role in immune cell migration and function is significant.<br>*   **UBC (Ubiquitin C):** A highly expressed gene involved in protein degradation and cellular stress responses. High expression is common in metabolically active cells.<br>*   **YWHAZ (Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta):** A 14-3-3 protein involved in various cellular processes, including signal transduction. High expression is common in many cell types.<br>*   **PABPC1 (Poly(A)-Binding Protein Cytoplasmic 1):** Involved in mRNA stability and translation. High expression indicates active gene expression and protein synthesis.<br>*   **NCL (Nucleolin):** A major nucleolar protein involved in ribosome biogenesis and other cellular processes. High expression is common in actively transcribing cells.<br>*   **BTG1 (B-cell Translocation Gene 1):** An anti-proliferative gene. Its expression can be variable depending on the activation state.<br>*   **JUND (Jun D Proto-Oncogene):** A component of the AP-1 transcription factor complex, involved in cell proliferation, differentiation, and apoptosis. Its expression can indicate cellular activation or stress.<br><br>**3. Cross-reference Known Databases:**<br><br>*   **Azimuth (Human Large Intestine):** Searching for these markers in Azimuth's human large intestine reference dataset would strongly point towards **NK cells** or **CD8+ T cells**, particularly effector or activated subsets.<br>*   **Human Cell Atlas (HCA):** Similar to Azimuth, HCA data for intestinal immune cells would show strong enrichment of NKG7, KLRD1, GZMA, GZMM in NK cells and cytotoxic T cells.<br>*   **PanglaoDB:** A quick search for "NKG7", "KLRD1", "GZMA", "GZMM" consistently lists NK cells and cytotoxic T cells as top hits across various tissues.<br>*   **ImmGen:** For more detailed immune cell subsets, ImmGen data would confirm the specific expression patterns within NK cell and T cell lineages.<br><br>The combination of **NKG7, KLRD1, GZMM, GZMA** is highly specific for cytotoxic lymphocytes. The presence of **TRGC2** adds a layer of complexity, suggesting a potential gamma-delta T cell component.<br><br>**4. Determine the Most Probable General Cell Type:**<br><br>Based on the overwhelming presence of cytotoxic granule proteins (GZMA, GZMM) and NK cell-specific receptors (NKG7, KLRD1), the most probable general cell type is **Cytotoxic Lymphocytes**.<br><br>**5. Identify the Top 3 Most Probable Sub Cell Types:**<br><br>1.  **Natural Killer (NK) Cells:** This is the most likely candidate. The strong co-expression of NKG7, KLRD1, GZMA, and GZMM is a hallmark of NK cells. NK cells are abundant in the large intestine and play a crucial role in immune surveillance against infected and cancerous cells. The high expression of ribosomal proteins suggests an active, potentially proliferating or highly functional state.<br>2.  **Effector/Cytotoxic CD8+ T Cells:** While NKG7 and KLRD1 are more characteristic of NK cells, they can also be expressed by a subset of activated CD8+ T cells, particularly those with NK-like features (NKT-like CD8+ T cells). The presence of GZMA and GZMM is also characteristic of cytotoxic CD8+ T cells. The lack of typical CD3/CD8 markers in the provided list makes it harder to definitively distinguish from NK cells without more markers, but it remains a strong possibility given the cytotoxic profile.<br>3.  **Gamma-Delta (Œ≥Œ¥) T Cells:** The presence of TRGC2 is a direct indicator of gamma-delta T cells. A subset of gamma-delta T cells, particularly those in mucosal tissues like the intestine, can exhibit cytotoxic functions and express granzymes (GZMA, GZMM) and NK receptors (NKG7). This makes them a plausible candidate, especially given their unique role in mucosal immunity.<br><br>**Most Likely Subtype:**<br><br>Given the strong and consistent expression of **NKG7, KLRD1, GZMM, and GZMA**, the most likely subtype is **Natural Killer (NK) Cells**. While cytotoxic CD8+ T cells and gamma-delta T cells can express some of these markers, the combination and high ranking of NKG7 and KLRD1 strongly favor an NK cell identity. The presence of TRGC2 suggests that a subset of these cells might be gamma-delta T cells with an NK-like cytotoxic phenotype, or it could indicate a mixed population. However, if forced to pick the *most* likely single subtype based on the *entire* list, NK cells stand out due to the prominence of their defining markers.<br><br>**6. Provide a Concise Summary of Your Analysis:**<br><br>The cluster is identified as **Natural Killer (NK) Cells**. This annotation is primarily driven by the high expression of key cytotoxic lymphocyte markers, including **NKG7, KLRD1, GZMM, and GZMA**, which are definitive for NK cells and cytotoxic T cells. The strong presence of NK-specific receptors (NKG7, KLRD1) alongside granzymes strongly points towards an NK cell identity. While TRGC2 suggests a potential gamma-delta T cell component, the overall marker profile is most consistent with active NK cells, which are crucial immune surveillance cells in the large intestine. The high expression of ribosomal proteins indicates a metabolically active and potentially highly functional or proliferating state.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Cytotoxic Lymphocytes</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Natural Killer (NK) Cells</li><li>Effector/Cytotoxic CD8+ T Cells</li><li>Gamma-Delta (Œ≥Œ¥) T Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li>gamma-delta T cells with an NK-like cytotoxic phenotype</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">98</div>
                        <div class="scoring-content">
                            The annotation provided is highly accurate and demonstrates a strong understanding of single-cell marker interpretation.<br><br>**Strengths:**<br><br>1.  **Correct Identification of Key Markers:** The agent correctly identified and prioritized the most informative markers for cytotoxic lymphocytes: NKG7, KLRD1, GZMM, and GZMA. These are indeed hallmark genes for NK cells and cytotoxic T cells.<br>2.  **Detailed Functional Analysis:** The breakdown of each key functional marker is excellent, providing biological context for why each gene is relevant (e.g., NKG7 involved in granule exocytosis, GZMM/GZMA for inducing apoptosis).<br>3.  **Consideration of Ribosomal and Housekeeping Genes:** The agent appropriately recognized the ribosomal protein genes (RPS/RPL) and common housekeeping genes (TMSB4X, UBC, YWHAZ, PABPC1, NCL) as indicators of high metabolic activity, which is characteristic of active immune cells, rather than misinterpreting them as specific cell type markers. This shows a nuanced understanding of gene expression profiles.<br>4.  **Balanced Consideration of Subtypes:** The agent did not over-focus on a single marker but considered the combination of markers. It correctly identified NK cells as the most likely candidate given the combination of NKG7, KLRD1, GZMM, and GZMA. It also appropriately considered effector CD8+ T cells and gamma-delta T cells as strong possibilities, especially due to TRGC2, and articulated the reasons for and against each.<br>5.  **Acknowledgement of Complexity (TRGC2):** The agent handled the TRGC2 marker very well, recognizing its specificity for gamma-delta T cells and integrating it into the interpretation by suggesting a potential mixed population or a gamma-delta T cell subset with NK-like features. This demonstrates an ability to deal with potentially ambiguous or overlapping marker profiles.<br>6.  **Contextual Awareness (Cluster Origin):** Although not explicitly stated in the analysis steps, the final summary implicitly considers the "human large intestine" origin, noting that NK cells are crucial immune surveillance cells in this tissue.<br>7.  **Concise and Clear Summary:** The final summary effectively condenses the detailed analysis into a clear and scientifically sound conclusion.<br>8.  **Marker Rank Consideration:** While not explicitly mentioning the "marker appears first is more important" rule, the analysis implicitly followed this by giving high importance to NKG7, which appeared early in the list, and other definitive cytotoxic markers. The agent clearly prioritized the most specific and informative markers.<br><br>**Weaknesses/Minor Suggestions:**<br><br>1.  **Explicitly Address Marker Rank:** While the agent implicitly considered the marker rank by focusing on the most informative markers, explicitly stating that early markers (like NR3C1, which is glucocorticoid receptor, not directly relevant to the dominant signature) were considered and deprioritized or recognized as less specific might add another layer of robustness to the justification. However, given the strong cytotoxic signature, this is a very minor point.<br>2.  **Slightly More Detail on Non-Key Markers:** For markers like NR3C1, CD52, SRSF7, etc., a brief mention of why they are less specific or not driving the primary annotation could be beneficial, even if it's just to confirm they were considered and ruled out as primary drivers. However, the current approach of focusing on the 'key functional' and 'key cell type' markers is efficient and effective.<br><br>Overall, the annotation is excellent. It demonstrates a deep biological understanding, a systematic approach to marker analysis, and the ability to synthesize complex information into a coherent and accurate cell type identification. The consideration of multiple markers, the appropriate weighting of specific vs. general markers, and the nuanced discussion of potential subtypes make this a high-quality annotation.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    